HLA-A and ependymoma: Next, we performed immunogenicity testing in EPN patients and healthy donors to analyze spontaneous, ependymoma-specific T cell responses in EPN patients and tested for the presence of memory T cells against the previously identified HLA-A*02:01 restricted peptide FLDS.